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ABSTRACT Plasmids have largely contributed to the spread of antimicrobial resist-
ance genes among Staphylococcus strains. Knowledge about the fitness cost that
plasmids confer on clinical staphylococcal isolates and the coevolutionary dynamics
that drive plasmid maintenance is still scarce. In this study, we aimed to analyze the
initial fitness cost of plasmids in the bacterial pathogen Staphylococcus aureus and
the plasmid-host adaptations that occur over time. For that, we first designed a
CRISPR (clustered regularly interspaced palindromic repeats)-based tool that enables
the removal of native S. aureus plasmids and then transferred three different plas-
mids isolated from clinical S. aureus strains to the same-background clinical cured
strain. One of the plasmids, pUR2940, obtained from a livestock-associated methicil-
lin-resistant S. aureus (LA-MRSA) ST398 strain, imposed a significant fitness cost on
both its native and the new host. Experimental evolution in a nonselective medium
resulted in a high rate pUR2940 loss and selected for clones with an alleviated fit-
ness cost in which compensatory adaptation occurred via deletion of a 12.8-kb plas-
mid fragment, contained between two ISSau10 insertion sequences and harboring
several antimicrobial resistance genes. Overall, our results describe the relevance of
plasmid-borne insertion sequences in plasmid rearrangement and maintenance and
suggest the potential benefits of reducing the use of antibiotics both in animal and
clinical settings for the loss of clinical multidrug resistance plasmids.
IMPORTANCE Plasmids are major agents in the spread of antibiotic resistance genes
among bacteria. How plasmids and their hosts coevolve to reduce the fitness cost
associated with plasmid carriage when bacteria grow in an antibiotic-free environ-
ment is not well understood. Here, we investigated the cost and the genetic adapta-
tions that occur during evolution in the absence of antibiotics when the bacterial
pathogen Staphylococcus aureus acquires a new plasmid. Our results show the occur-
rence, at the end of evolution, of plasmid rearrangements mediated by insertion
sequences that lead to the loss of antimicrobial resistance genes from the plasmid
and an alleviated fitness cost. Our results thus highlight the probable benefits of
reducing the use of antibiotics in management programs for the selection of S. aur-
eus clones carrying plasmids that no longer confer resistance.
KEYWORDS plasmid, fitness cost, evolution, Staphylococcus aureus, CRISPR, insertion
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Plasmids are circular extrachromosomal DNA elements capable of semiautonomousreplication by recruiting host cell enzymes (1). Plasmids carry genes necessary for
plasmid replication and transmission, and the so-called accessory genes that under
specific environmental conditions provide beneficial traits, such as antibiotic resist-
ance, tolerance to heavy metals, virulence, metabolism of carbon sources, or root nod-
ulation (2). Many plasmids are large or found in high copy numbers, and logic suggests
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that in the absence of selection for plasmid-encoded traits, the fitness cost of plasmid
carriage should be higher than its benefits and, consequently, clones lacking the plas-
mid should outcompete the plasmid-bearing population in few generations (3, 4).
Some plasmids solve this puzzle by moving the beneficial genes to the bacterial chro-
mosome and then remaining as smaller plasmids or simply disappearing (5). However,
this strategy seems not to be the preferred solution, since plasmids containing acces-
sory genes are widely distributed, indicating that mechanisms have been developed to
persist in the host, independently of the presence of positive selection. In 2012, a semi-
nal publication by Harrison and Brockhurst proposed that the paradox in plasmid per-
sistence can be explained, at least in part, by compensatory mutations that the plasmid
and the host accumulate over time to alleviate the fitness cost (6). Since then, several
studies have pursued this line of investigation and found that host-plasmid coevolu-
tion is easily achievable in the laboratory through mutations that can occur in the plas-
mid, the bacterial chromosome, or both (7–10). However, the rules governing plasmid
fitness cost remain largely unexplored, and thus, it is not possible to predict the evolu-
tion of the same plasmid in different bacterial clones and the fitness effects of different
plasmids in the same strain (4).
Staphylococcus aureus is a major human pathogen routinely isolated as a commen-
sal organism in more than a third of the human population. In particular, methicillin-re-
sistant Staphylococcus aureus (MRSA) is a high-priority pathogen according to the
World Health Organization list for which new antibiotics are urgently needed. Most
natural strains of S. aureus contain different types of mobile genetic elements (MGEs),
including plasmids, transposons, insertion sequences, bacteriophages, and pathogenic-
ity islands, that facilitate the acquisition of genes encoding mechanisms of resistance
against antimicrobials, biocides, and heavy metals (11). Regarding plasmids, most S.
aureus clinical isolates harbor one to three plasmids that can carry antibiotic and anti-
septic resistance genes (responsible for resistance to b-lactams, tetracycline, erythro-
mycin, kanamycin, vancomycin, trimethoprim, chloramphenicol, mupirocin, linezolid,
teicoplanin, heavy metals, quaternary ammonium compounds, and chlorhexidine),
which provide an advantage to the bacterium when the antibiotic and the biocide are
present (12). Very often, the same plasmid accumulates multiple antimicrobial resist-
ance genes, which increases the possibilities of selection for plasmid-encoded traits
(13). Current knowledge about the fitness cost associated with the carriage of antibi-
otic resistance plasmids in S. aureus is scarce. The lab of J. Lindsay showed that differ-
ences in fitness between two prevalent MRSA clones were unrelated to the presence
of large antibiotic resistance plasmids (14). On the other hand, a recent study investi-
gating the coevolution over the last 32 years of the pSK1 plasmid family in the
Australian S. aureus ST239 MRSA clade revealed that pSK1 plasmid maintenance is
linked to multiple structural variations caused by the insertion sequences IS256 and
IS257 (15). In summary, we still have a limited understanding of how plasmids and S.
aureus have coevolved in order to reduce the fitness cost that plasmid carriage pro-
duces when bacteria grow in an antibiotic-free environment, as occurs when patients
finish antibiotic treatment. This knowledge could have important consequences in the
design of antibiotic management plans, especially if plasmid-bearing bacteria show a
lower fitness than plasmid-free bacteria in the absence of antibiotics.
In this work, we addressed the fitness cost and the mechanisms of coevolution of
natural plasmids of S. aureus. For that, we generated a CRISPR (clustered regularly inter-
spaced palindromic repeats)-based tool to remove plasmids from natural isolates of S.
aureus. One of the resulting plasmid-free strains was transformed with three different
plasmids isolated from clinical MRSA strains representative of livestock-associated, hos-
pital, and community environments, and then the initial cost upon entering this new
host was calculated and experimental evolution in the absence of selection was
assayed. Our results showed that two plasmids did not produce any discernible cost
and were stably maintained during evolution. In contrast, a third plasmid entailed a
high fitness cost and was rapidly lost in the absence of selective pressure. Adaptation
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over time was dependent on plasmid rearrangements through plasmid-borne ISSau10
insertion sequences and driven by the cost of a plasmid region comprising several anti-
microbial resistance genes. These results indicate that insertion sequence-mediated
loss of a plasmid region encompassing resistance genes alleviates the cost associated
with plasmid carriage in the absence of antibiotics and suggest that limiting antibiotic utili-
zation may select for mutated plasmid-carrying clones that no longer confer resistance.
RESULTS
Curing of naturally occurring plasmids of S. aureus using a CRISPR-Cas9
system. In order to develop an efficient plasmid curing tool for S. aureus, we con-
structed a plasmid that enables CRISPR-Cas9 precise targeting of S. aureus plasmid
DNA. For that, the cas9 gene was cloned downstream of the tetracycline-inducible pro-
moter Pxyl/tetO inside a pCN38 backbone in which the replication origin was changed by
the temperature-sensitive origin of replication pE194ts-ori, leading to a thermosensitive
plasmid that we named pEMPTY (see Fig. S1 in the supplemental material). Then, to
identify guide RNAs that target the majority of natural plasmids found in S. aureus, we
searched for fully sequenced plasmids from the genus Staphylococcus in the NCBI
RefSeq database. Replication origins (oriT) and rep and mob genes, which codify repli-
cation initiation proteins and relaxases, respectively, were queried using the online
platform sgRNA scorer 2.0 (16) to predict guide RNA activity on input sequences. Only
target sequences that were present in 10 or more plasmids with a score equal to or
greater than 0.5 were selected (Data Set S1). From these, the sequence targeted by
guide RNA 2 (gRNA2) was selected, since it was found in 56% of S. aureus plasmids.
Then, gRNA2 was fused to the transactivating RNA (tracrRNA) and cloned under the
control of the constitutive strong promoter SP01 in plasmid pEMPTY, leading to the
final thermosensitive plasmid curing tool pEMPTY::sgRNA2 (Fig. 1A; also, see Fig. S1).
To test the efficiency of our plasmid-curing system, we first transformed S. aureus
RN4220 with seven unrelated plasmids of similar size and diverse origins targeted by
single guide RNA 2 (sgRNA2) (pMW2, pUR2940, pN315, pLAC-p03, pUR1902, pUR3912,
and pUR1841) (Table 1). Also, plasmid pUR2355 was used as a control of plasmid cur-
ing unavailability because it does not contain the gRNA2 target DNA sequence. S. aur-
eus RN4220 plasmid-bearing strains were transformed with pEMPTY::sgRNA2, cas9
expression was induced with anhydrotetracycline, and bacteria were plated on general
Trypticase soy agar (TSA) medium and TSA containing a selective agent to calculate
curing rates (Fig. 1B). All S. aureus RN4220 derivatives, except for the control strain
bearing pUR2355, became sensitive to the selective agent with plasmid curing efficien-
cies that ranged between 98 and 100% of the total population (Table 2).
Next, we evaluated the efficacy of pEMPTY::sgRNA2 for curing plasmids in their orig-
inal wild-type strains where transformation efficiencies can be compromised. In all the
strains, our system showed plasmid curing rates similar to those previously obtained in
the laboratory strain RN4220 (Table 2). To ensure that curing efficiencies shown in
Table 2 were due to the CRISPR-Cas9 activity of pEMPTY::sgRNA2, the pEMPTY plasmid,
which does not carry any sgRNA, was used in parallel. In this case, plasmid mainte-
nance at the end of the curing experiment was 100% in all cases (data not shown).
Altogether, these results demonstrate that pEMPTY::sgRNA2 can be efficiently used
for curing naturally occurring plasmids from S. aureus isolates of diverse origins. The
replacement of sgRNA2 by a different guide RNA would allow the removal of plasmids
that are not targeted by sgRNA2.
Evaluation of the fitness cost and evolutionary adaptation associated with
plasmid carriage in S. aureus. The pEMPTY::sgRNA2 plasmid-curing tool enables the
study of the fitness of clones with and without a particular plasmid, and also, it permits
construction of new bacterium-plasmid associations. Thus, aiming to investigate the
fitness cost produced by different plasmids in a cured S. aureus strain, we transformed
the plasmid-free derivative of S. aureus MW2 strain (MW2 PFt0) with plasmids pUR2940,
pN315, and pLAC-p03 (Fig. 2A and Fig. S2). S. aureus MW2 was selected as the recipient
strain because of its major significance as a prototype community-associated
Fitness Cost of Plasmids in Staphylococcus aureus ®















































methicillin-resistant S. aureus (CA-MRSA) strain of the clonal complex 1 (CC1)/USA400
lineage (17). On the other hand, the above-mentioned plasmids (Table 1) were used
because they are carried by MRSA strains representative of the livestock-associated
CC398 lineage (LA-MRSA C2940 strain) (18), health care-associated CC5/USA100 line-
age (HA-MRSA N315 strain) (19), and community-associated CC8/USA300 lineage (CA-
MRSA LAC strain) (20) (Table S1). Also, MW2 PFt0 was transformed with its own original
pMW2 plasmid as a control for neutral fitness cost (Fig. 2A and Fig. S2). Three plasmid-
carrying clones selected from three independent transformation rounds were studied
in each case (Fig. 2B). Analysis of the initial fitness cost, measured as the differences in
both the area under the growth curve and the duration of the lag phase between
MW2 PFt0 and plasmid-bearing clones, revealed that only plasmid pUR2940 caused a
significant decrease in the area under the growth curve and also a delay in the lag
phase (Fig. 3 and Fig. S3).
In order to analyze the evolution of newly acquired plasmids over time in the ab-
sence of selection, we propagated the MW2 plasmid-carrying strains in antibiotic-
free culture medium for 35 days, diluting the culture (1:1,000) every 12 h, which
FIG 1 Plasmid map of pEMPTY::sgRNA2 and the plasmid curing process in S. aureus using the
pEMPTY::sgRNA2 system. (A) The shuttle vector pEMPTY::sgRNA2 contains the cas9 gene downstream
of the tetracycline-inducible promoter Pxyl/tetO to guarantee regulation of curing functionality, the
temperature-sensitive origin of replication pE194ts-ori, which allows the loss of the vector system by
increasing the temperature to 37°C, and a small guide RNA, consisting of guide RNA 2, which targets
S. aureus plasmids fused to the scaffold tracrRNA sequence, downstream of the constitutive SP01
promoter. (B) pEMPTY::sgRNA2 is transformed into a S. aureus strain containing the target plasmid for
curing, and transformants are selected on medium containing chloramphenicol as a selective agent.
Cells are transferred into liquid TSB medium containing chloramphenicol and anhydrotetracycline (ATc),
and the culture is incubated overnight at 28°C to allow cas9 gene expression and, thus, cleavage of
target plasmids directed by guide RNA 2. The culture is plated on TSA containing chloramphenicol and
antibiotic (cadmium, lincomycin, or erythromycin) selective TSA, and cured cells are identified by
antibiotic sensitivity and PCR screening. A colony of cured cells is incubated overnight in nonselective
TSB medium at 37°C, and the culture is plated on nonselective TSA and incubated overnight at 37°C to
select a cured colony that has lost plasmid pEMPTY::sgRNA2.
Dorado-Morales et al. ®
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corresponds to approximately 640 generations of bacterial evolution by the end of
the experiment (Fig. 2B). Evaluation of the dynamics of plasmid carriage over the
35 days of the experiment showed that while the control plasmid pMW2 and also
plasmids pN315 and pLAC-p03 were stably maintained by the entire population,
the frequency of pUR2940 plasmid-carrying cells rapidly declined, with almost
100% of the population of all three evolved clones being plasmid free by the end of
the assay (Fig. 4). At day 35, cultures were plated on TSA medium containing
0.05mM cadmium, and one plasmid-bearing clone was isolated from each culture.
Analysis of the plasmid copy number in all MW2 plasmid-bearing clones at the be-
ginning of the evolution process and also in isolated plasmid-carrying clones at the
end of the experiment showed that plasmid copy number did not change during
bacterial evolution in all cases (Fig. S4). Together, these results showed that, from
the three plasmids analyzed, pUR2940 produced an evident cost in MW2 strain that
contributed to a decline of the plasmid frequency in the population over time.
Next, to discern whether the pUR2940 plasmid still produced a cost in the small
population that carried the plasmid at the end of the evolution process or whether
compensatory adaptation had taken place, pUR2940 was cured in MW2 pUR2940
evolved clones (MW2 PFt35 pUR2940t35) and the fitness of evolved plasmid-bearing
clones was compared to that of their respective cured clones (MW2 PFt35) (Fig. 2B and
Fig. 5A). Results showed that pUR2940 no longer produced a cost in two of the three
clones analyzed, indicating that compensatory adaptation had occurred during evolu-
tion to overcome the cost associated with pUR2940 carriage (Fig. 5B).
Elucidation of the genetic basis of compensation of the cost produced by
plasmid pUR2940. To gain insight into the genetic basis of MW2 compensatory adap-
tation to plasmid pUR2940 present in evolved MW2 PFt35 pUR2940t35 clones, two strat-
egies were followed (21) (Fig. 2C). First, to analyze the contribution of chromosomal
modifications to plasmid cost alleviation, we transformed the evolved cured clones
(MW2 PFt35) with the ancestral pUR2940t0 plasmid, and fitness was compared prior to
and after transformation with the plasmid (Fig. 6A). All three evolved, cured clones
transformed with ancestral pUR2940t0 showed low fitness compared to their nontrans-
formed counterparts (i.e., they showed a clear decrease in the area under the growth
curve and a delay in the lag phase) (Fig. 6B). These results suggested that chromo-
somal modifications were not involved in pUR2940 carriage adaptation. Second, to
investigate the contribution of pUR2940 plasmid mutations to cost alleviation, we
transformed the ancestral MW2 plasmid-free strain, MW2 PFt0, with the different
pUR2940t35 plasmids isolated from the three evolved MW2 PFt35 pUR2940t35 clones
TABLE 2 Plasmid curing efficiencies achieved with the use of pEMPTY::sgRNA2

















aPlasmid pUR2355 does not contain the guide RNA 2 target DNA sequence.
bPlasmid pUR3912 was present as an extrachromosomal element as well as integrated into the chromosome of
strain C3912 (52).
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(Fig. 7A). pUR2940 isolated from the evolved adapted MW2 PFt35 pUR2940t35 clones 2
and 3 did not produce a cost when transformed into the ancestral MW2 plasmid-free
strain (Fig. 7B). In contrast, the pUR2940 plasmid variant producing a fitness cost in the
evolved MW2 PFt35 pUR2940t35 clone 1 also produced a cost when it was transformed
into the ancestral MW2 plasmid-free strain. Altogether, these results suggested that
compensatory adaptation to plasmid pUR2940 present in evolved MW2 PFt35 pUR2940t35
can occur through mutations in plasmid pUR2940 during the evolution process.
To investigate the changes in pUR2940t35 responsible for the adaptation, we
sequenced the pUR2940t35 variants isolated from the two evolved adapted clones and
FIG 2 Experimental design of the evolution process of S. aureus MW2 plasmid-containing clones and
analysis of the compensatory adaptation to plasmid pUR2940. Bacterial cells are represented by
brown circles and include chromosomes depicted in blue. Plasmids are indicated by colored circles.
The letter “e” indicates either an evolved strain or evolved plasmid.
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compared the retrieved sequences to that of pUR2940t35 isolated from the nonadapted
clone and also to the ancestral plasmid pUR2940t0. As predicted by the fitness experi-
ments, no mutations were found in the plasmid from the nonadapted clone while a
fragment of 12,880 bp was lost in both plasmid variants isolated from adapted clones
(Fig. 8). Its loss seemed to be the result of homologous recombination involving two
copies of the insertion sequence ISSau10. This fragment was not found as an inde-
pendent replicative unit (it includes replication initiation protein genes, although most
FIG 3 Initial fitness cost after transformation of plasmid-free MW2 strain with plasmids pMW2,
pUR2940, pN315, and pLAC-p03. The fitness of plasmid-free MW2 (MW2 PFt0) was compared with that
of the wild-type MW2 strain and MW2 PFt0 transformed with plasmids pMW2, pUR2940, pN315, and
pLAC-p03 (three independently transformed clones [C1, C2, and C3] were analyzed in each case). (A)
Area under the growth curve; (B) duration of the lag phase. Data were collected during growth in
TSB medium for 24 h at 37°C with shaking. Ten technical replicates were used for each of the tested
clones. Results from one representative experiment of at least three independent experiments are
shown. Plasmid pUR2940 produced a significant cost in cured strain MW2. Statistical analysis was
carried out using a one-way analysis of variance combined with the Bonferroni multiple post hoc test.
*, P , 0.05; ***, P , 0.001; ns, no significant difference.
FIG 4 Plasmid stability in the bacterial population during the evolution process. The proportion of
plasmid-bearing bacteria is shown as a function of the evolution time. Every 7 days during the
evolution process, cultures of the three clones corresponding to each MW2 PF strain transformed
with plasmids pMW2, pUR2940, pN315, and pLAC-p03 were plated on TSA medium. One hundred
colonies from each culture were streaked on TSA and TSA containing 0.05mM Cd as a plasmid-
selective agent. The numbers of total and resistant colonies were determined, and the percent
plasmid-carrying colonies was calculated. Data are means and standard deviations of values obtained
from the three individual clones analyzed in each case.
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likely incomplete), nor was it inserted into the host chromosome of the evolved strain.
Notably, the lost fragment contains genes that provide resistance to macrolides, linco-
samides, and streptogramin B (ermC and ermT), trimethoprim (dfrK), and tetracycline
(tetL). This fragment also includes the MOBV relaxase gene and thus, the conjugative
mobilization of these evolved plasmid variants would be impaired.
Finally, in order to confirm that this new plasmid variant was indeed completely sta-
ble in the MW2 strain, we propagated the ancestral strain MW2 PFt0 transformed with
pUR2940t35 evolved plasmids for 14 days, which corresponds to approximately 256
generations of bacterial evolution, following the previously described evolution pro-
cess (Fig. 2B). After 14 days of evolution, the percentage of plasmid carriage was calcu-
lated, and as expected, the two new adapted variants pUR2940t35 were present in
100% of the population whereas the nonadapted plasmid pUR2940t35 was almost lost
(4% of plasmid-bearing bacteria). Overall, these results demonstrated that pUR2940
plasmid reorganization is sufficient to alleviate the cost produced in the MW2 strain.
FIG 5 Final fitness cost of plasmid pUR2940 in strain MW2 after the evolution process. (A) To elucidate
if plasmid pUR2940 still imposed a cost in the evolved populations, the three MW2 pUR2940 evolved
clones (MW2 PFt35 pUR2940t35 C1, C2, and C3) were cured, leading to their respective cured clones
(MW2 PFt35 C1, C2, and C3). The fitness of all clones was compared. (B) Area under the growth curve
(left) and duration of the lag phase (right). Data were collected during growth in TSB medium for 24h
at 37°C with shaking. Ten technical replicates were used for each of the tested strains. Results from one
representative experiment of at least three independent experiments are shown. Statistical analysis was
carried out using the Mann-Whitney U test. ***, P , 0.001; ns, no significant difference.
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pUR2940 also imposes a cost in its natural host that can be compensated for
via ISSau10-mediated deletion of a costly region from the plasmid. The above
results indicated that the pUR2940 plasmid produces a noticeable cost in the MW2
strain that can be alleviated through plasmid rearrangements when cultured in the ab-
sence of antibiotic pressure. Based on this, we wondered whether pUR2940 also
imposes a cost in the original S. aureus strain (C2940) under conditions in which plas-
mid genes do not provide any benefit to the host. A comparison of the fitness of the
C2940 strain and its respective cured derivative, when grown in the absence of selec-
tion, confirmed that pUR2940 produces a significant cost in its original host (Fig. 9).
Indeed, when C2940 was propagated in liquid medium without antibiotics for 14 days,
only 4.6% of the cells retained the ancestral plasmid. Given that the C2940 strain shows
an intrinsic high resistance to cadmium (18), we were unable to select cadmium-resist-
ant and erythromycin-sensitive clones, which would presumably harbor an evolved
pUR2940 plasmid. To analyze if reorganized pUR2940 variants appear during C2940
FIG 6 Compensatory adaptation to pUR2940 is not based on changes in the chromosome of host
MW2 bacteria. (A) The first strategy to analyze the origin of MW2 compensatory adaptation to pUR2940.
Evolved cured clones MW2 PFt35 C1, C2, and C3 were transformed with the ancestral pUR2940t0 plasmid.
(B) The fitness of MW2 PFt35 C1, C2, and C3 was compared with that of transformed clones with ancestral
pUR2940t0. The area under the growth curve (left) and the duration of the lag phase (right) are shown.
Data were collected during growth in TSB medium for 24h at 37°C with shaking. Ten technical replicates
were used for each of the tested strains. Results from one representative experiment of at least three
independent experiments are shown. Statistical analysis was carried out using the Mann-Whitney U test.
***, P , 0.001.
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evolution in the absence of selection, a plasmid extraction was performed from the
whole evolved culture after 14 days of propagation in Trypticase soy broth (TSB) me-
dium, and the PCR product of primers 412 and 414 was examined through agarose gel
electrophoresis. A band with the size of the expected evolved pUR2940 plasmid was
excised and analyzed by sequencing, which yielded data showing deletion of a frag-
ment similar to the one occurring in pUR2940t35 isolated from the MW2 evolved adapted
clones (Fig. 8). Hence, these results confirmed the occurrence of pUR2940 reorganization
via the ISSau10 insertion sequence that leads to the loss of antimicrobial resistance
genes when the C2940 strain encounters an antibiotic-free environment.
DISCUSSION
Location of genes in plasmids rather than in the chromosome offers benefits to bac-
teria because it provides higher levels of gene expression, different versions of a gene
FIG 7 Compensatory adaptation of MW2 to pUR2940 in clones 2 and 3 is due to changes in
pUR2940. (A) The second strategy to analyze the origin of MW2 compensatory adaptation to pUR2940.
The ancestral MW2 plasmid-free strain, MW2 PFt0, was transformed with pUR2940t35 plasmids isolated
from the three evolved MW2 PFt35 pUR2940t35 clones. (B) Fitness of ancestral MW2 PFt0 was compared
before and after transformation with pUR2940t35 from evolved clones. The area under the growth curve
(left) and the duration of the lag phase (right) are shown. Data were collected during growth in TSB
medium for 24h at 37°C with shaking. Ten technical replicates were used for each of the tested strains.
Results from one representative experiment of at least three independent experiments are shown.
Statistical analysis was carried out using the Mann-Whitney U test. ***, P , 0.001; ns, no significant
difference.
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that coexist in the same cell (heterozygosity) and an increase in the mutational supply
and hence the chance of acquiring mutations and because it facilitates the exchange
of genes and the acquisition of new capacities (22). However, the presence of a plas-
mid also imposes a fitness cost, and therefore, the fact that plasmids are so abundant
in bacteria living in competitive environments when the selection pressure has disap-
peared, for instance, a patient after completion of antibiotic treatment, seems counter-
intuitive. Most of our current understanding about plasmid fitness and evolution has
been obtained from the study of Gammaproteobacteria, and it is important to examine
whether similar rules govern plasmid evolution in other clinically relevant bacterial
species (7, 8, 10, 23, 24). In this study, we investigated the fitness cost associated with
plasmid carriage in clinical isolates of S. aureus, where these mobile genetic elements
are major agents in the dissemination of multidrug resistance determinants.
The best method to demonstrate the relationship between the presence of the
plasmid and fitness cost is the elimination of the plasmid (curing) from the bacterial
population. The cost should disappear in cured derivatives and reappear when the
plasmid is reintroduced into the cured strain. Plasmid curing has been traditionally
FIG 8 Comparison of the ancestral plasmid pUR2940 and its evolved variants. The ancestral plasmid
pUR2940t0, evolved plasmid pUR2940t35 from MW2 evolved clones 1, 2, and 3, and evolved plasmid
pUR2940t14 isolated from evolved strain C2940 are compared. Image visualization was carried out
with BLAST Ring Image Generator (BRIG), which shows the similarity between the central reference
sequence pUR2940t0 and the other variants as concentric rings. ORFs, open reading frames; CDS,
coding sequence.
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performed by prolonged bacterial growth in the presence of chemical and physical
agents, some of which introduce mutations in the DNA or interfere specifically with its
replication (25). The risk of these strategies is that they favor the accumulation of muta-
tions, something that is incompatible with investigating the molecular basis of plasmid
fitness cost. We addressed this methodological limitation by generating a CRISPR-
based tool (the pEMPTY plasmid) that requires only the transformation of a given strain
to remove the existing plasmid. In the present study, we used a guide RNA that targets
56% of the currently known plasmids in S. aureus. An easy way to expand the chance
of plasmid targeting would be to include additional sgRNA in the pEMPTY plasmid.
We used a clinical S. aureus strain from which we removed its native plasmid (plas-
mid-free S. aureus MW2) to simulate the scenario of the physical arrival of a plasmid
into a new host. The analysis of the fitness cost produced upon arrival revealed some-
what surprising results showing that two plasmids (pN315 and pLAC-p03) did not
entail any noticeable cost. These two plasmids are slightly larger than the native MW2
plasmid and contain a different set of antimicrobial resistance genes (Table 1). A rea-
sonable explanation for these results is that during the adaptive evolution of S. aureus
MW2 to its native plasmid, bacteria accumulated chromosomal changes to alleviate
the cost associated with plasmid carriage, and thus, the introduction of a new plasmid
does not require additional coevolution steps. In addition, pMW2, pN315, and pLAC-
p03 encode toxin-antitoxin systems that might prevent plasmid loss even in the ab-
sence of selective pressure, while pN315 and pMW2 encode bacteriocins that might
provide a competitive advantage to the plasmid-bearing cells (Table 1). In contrast,
plasmid pUR2940 entailed a high fitness cost both to its native host and the new S.
aureus MW2 PFt0 strain and was very unstable. pUR2940 is a multiresistant plasmid iso-
lated from a human methicillin-resistant S. aureus strain of the clonal lineage ST398
that carries several antibiotic resistance genes and three copies of the ISSau10 insertion
sequence (18). Importantly, neither toxin-antitoxin systems nor bacteriocins are
encoded in pUR2940 (Table 1). Coevolution of the plasmid and the host through serial
passages in an antibiotic-free medium selected for plasmids that had lost a 12.8-kb
plasmid region that is flanked by two ISSau10 elements and comprises all the antibiotic
resistance genes. The sequencing results suggest that deletion occurs via intramolecu-
lar recombination between two ISSau10 insertion sequences. ISSau10 belongs to the
IS6/IS26 family (26), whose members are involved in the mobilization of antibiotic re-
sistance genes in Gram-negative bacteria (23, 27). Thus, alleviation of the plasmid fit-
ness cost comes at the expense of losing all the antibiotic resistance determinants.
Notably, the deleted region was neither found as an independent replicon nor subse-
quently integrated into the host chromosome, ruling out the risky outcome of antimi-
crobial gene fixation.
A question raised by these results is how the deleted region entails such a high fit-
ness cost for the host. It is unsurprising that antibiotic resistance genes provide a selec-
tive advantage in the presence of antibiotics, but it is less clear why their presence can
FIG 9 Fitness cost of plasmid pUR2940 in its original host, strain C2940. Fitness of strain C2940 was
compared with that of its plasmid-free derivative C2940 PFt0. (Left) Area under the growth curve;
(right) duration of the lag phase. Data were collected during growth in TSB medium for 24 h at 37°C
with shaking. Ten technical replicates were used for each of the tested strains. Results from one
representative experiment of at least three independent experiments are shown. Statistical analysis
was carried out using the Mann-Whitney U test. **, P , 0.01; ***, P , 0.001.
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be so costly with little or no selective pressure. One possibility is that these genes are
expressed at very high levels so that transcription, translation, and/or the subsequent
interactions between the proteins responsible for antibiotic resistance and cellular net-
works affect bacterial physiology. Previous work in Escherichia coli showing that
expression of a plasmid-encoded tetracycline efflux pump is highly costly supports this
notion (28, 29). Alternatively, the transposase encoded by the IS may interact with
other mobile genetic elements carried in the bacterial genome and produce a reduc-
tion in bacterial fitness (3). The deleted fragment in the evolved plasmid variant
included, besides antibiotic resistance genes and ISSau10 copies, a Rep_1 rolling-circle
replication (RCR) initiation protein gene (most likely truncated in its 39-terminal region
by an ISSau10 copy) and a MOBV relaxase. These plasmid backbone genes might also
be responsible for plasmid cost. In fact, plasmid-host adaptations have previously been
shown to occur via mutations in the plasmid replication machinery (30) and in chromo-
somal genes interacting with replication proteins (31). Future research involving tar-
geted deletions from the pUR2940 plasmid will be conducted in order to identify
exactly what gene(s) is responsible for plasmid cost.
The resulting new evolved plasmid showed no detectable fitness cost, at least with
the resolution of the growth measurements used in our study. This plasmid, in the
future, might provide a backbone for the entry of a new carriage. The ISSau10 copy
that remains in the evolved plasmid variants could be a platform to promote cointe-
gration of another molecule also containing an ISSau10 copy via the conservative
transposition route or homologous recombination.
In-depth studies carried out in other bacteria have shown that adaptive evolution
in conditions selecting for plasmid carriage can increase plasmid stability by diminish-
ing the fitness cost of an initially costly plasmid-host association (7, 10, 23, 32, 33).
Thus, periods of selection may provide sufficient time for plasmid-host adaptations to
occur, enhancing plasmid persistence once selection is removed (7). Taking this into
account, our results showing that plasmid pUR2940 imposes a fitness cost in its native
S. aureus strain might indicate that long-term coevolution between the host and the
plasmid has not yet occurred. On the other hand, an increase in plasmid persistence as
a result of positive selection may not always be the case. It has been demonstrated
that antibiotic selection can lead to increased plasmid heterogeneity in E. coli and
maintenance of all plasmid-carrying hosts regardless of plasmid stability. Thus, con-
stant selection could interfere with the emergence of stable plasmid variants and thus
hinder long-term plasmid persistence (34). With regard to the impact of selective pres-
sures on pUR2940 maintenance in health care settings, further evolution analysis in
the presence of antibiotics will be necessary to investigate the molecular basis of
pUR2940 host adaptation during positive selection.
Finally, future investigations using in vivo animal models are necessary to confirm
that insertion sequences mediated rearrangement is a general strategy to reduce the
fitness cost of multidrug plasmid carriage in the absence of antibiotics. This knowledge
is critical to predict the evolution of plasmids containing insertion sequence elements
together with multidrug-resistant genes and may have a significant impact on the choice
of antibiotic regimens in order to decrease the probability of plasmid persistence.
MATERIALS ANDMETHODS
Bacterial strains, oligonucleotides, and culture conditions. Bacterial strains, plasmids, and oligo-
nucleotides used in this work are listed in Tables S1, S2, and S3, respectively. Escherichia coli strains were
grown in Luria-Bertani medium (LB; Conda-Pronadisa) at 37°C. S. aureus strains were routinely incubated
in Trypticase soy broth (TSB; Conda-Pronadisa) at 37°C. When required, media were supplemented with
appropriate antibiotics at the following concentrations: ampicillin (Amp), 100mg ml21; chloramphenicol
(Cm), 20mg ml21; cadmium (Cd), 0.05mM; erythromycin (Ery), 10mg ml21; and lincomycin (Lin), 8mg
ml21. Bacteriological agar (VWR) was used as a gelling agent. A stock solution of 10mg ml21 anhydrote-
tracycline (Cayman Chemical Company) in dimethyl sulfoxide (DMSO) was prepared and added to cul-
tures at 100 ng ml21 to induce the expression of cas9 (pEMPTY and derivatives).
DNAmanipulations. Routine DNA manipulations were performed using standard procedures unless
otherwise indicated. Oligonucleotides were synthesized by StabVida (Caparica, Portugal). FastDigest
restriction enzymes, Phusion DNA polymerase, and a rapid DNA ligation kit (Thermo Scientific) were
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used according to the manufacturer’s instructions. Plasmids were purified using a Macherey-Nagel plas-
mid purification kit according to the manufacturer’s protocol. To extract plasmids from S. aureus, an
extra step was included in the established protocol: after resuspension in buffer A1 and prior to the
addition of A2, the mixture was subjected to physical lysis using glass beads (FastPrep cell disrupter; 6 m
s21, 40 s). Plasmids were transformed in Escherichia coli by electroporation (1-mm cuvette; 200X, 25mF,
1,250 V; Gene Pulser X-Cell electroporator). S. aureus competent cells were generated as previously
described (35). All plasmids but pLAC-p03 were individually transformed in Staphylococcus aureus wild-
type and cured strains by electroporation (1-mm cuvette; 100X, 25mF, 1,250 V; Gene Pulser X-Cell elec-
troporator). All constructed plasmids were confirmed by Sanger sequencing.
Genomic DNA was extracted from 1ml of overnight cultures grown in antibiotic-free TSB medium
using a GenElute bacterial genomic DNA kit (Sigma) according to the manufacturer’s protocol.
Moving pLAC-p03 to RN4220. Plasmids extracted from S. aureus strain LAC(pLAC-p01 pLAC-p03)
were transformed into the laboratory strain RN4220, generating an RN4220 strain containing both plas-
mids. 80a phage lysate was generated as specified in reference 36. A culture of RN4220(pLAC-p01 pLAC-
p03) was infected with the 80a lysate at a multiplicity of infection of 0.1 until complete lysis was
reached. RN4220(pLAC-p01 pLAC-p03) lysate was filtered (0.2mm) and used to infect RN4220 wild-type
cells. Transductant selection was made in medium containing 100mM sodium citrate and 0.05mM cad-
mium as a selective agent. The presence of pLAC-p03 in Cd-resistant transductants was checked by plas-
mid extraction followed by PCR amplification using oligonucleotides 365 and 366. The absence of pLAC-
p01 was confirmed using primers 280 and 282.
Construction of pEMPTY::sgRNA2. The shuttle vector pEMPTY was constructed as follows (Fig. S1).
The cas9 gene and the transcriptional terminator for bacteriophage T7 RNA polymerase were PCR ampli-
fied from pFREE-Amp using primers 191 and 473 (25). The tetracycline-inducible promoter Pxyl/tetO was
amplified using the pRMC2 plasmid as a template and oligonucleotides 119 and 195 (37). A pCN38 back-
bone was amplified using oligonucleotides 474 and 189 (38). Then, In-Fusion cloning (In-Fusion HD clon-
ing kit; TaKaRa) was used to combine the three fragments described above. The resulting plasmid was
linearized with ApaI and EheI and ligated to the temperature-sensitive origin of replication pE194ts-ori
amplified from pMAD (39) using oligonucleotides 257 and 259, generating the thermosensitive plasmid
pEMPTY.
The module containing the strong constitutive promoter SP01 directing the expression levels of the
chimeric molecule composed of guide RNA 2 fused to the transactivating RNA (tracrRNA) was amplified
from pFREE-Amp (25) using oligonucleotides 448 and 475. The amplification product was cloned into
pJET1.2, digested with SmaI and AscI, gel purified, and cloned into pEMPTY, generating pEMPTY::
sgRNA2.
sgRNA site identification and database generation. The sequences of 358 fully sequenced staphy-
lococcal plasmids were retrieved from the RefSeq database (40) (release 83). From those plasmids,
sequences corresponding to origins of replication and origins of transfer (oriTs) were identified through
conventional alignments using BLASTn against previously annotated ori sequences in the RefSeq files
(NC_008356 [pLNU plasmids], NC_001995 [pSK plasmids], NC_001393 [pT181], NC_006974 [pACK6],
NC_005566 [pSK639], NC_005243 [pC223], and NC_005127 [pUB101]) and previously identified oriTs
(41). Sequences corresponding to rep and mob genes were extracted using HMMER3 (42) and MOBscan
software (43). Specific plasmid-related sequences previously described in the literature (44) were also
considered.
The online platform sgRNA scorer 2.0 (16) was then used to predict and identify sgRNA activity on
the previous plasmid-related sequence database. A score greater than or equal to 0.5, according to the
platform classifier, and virtual capability of action over 10 or more plasmids were the requirements
established for a target site to be selected. This information can be found in Data Set S1 in the supple-
mental material.
Plasmid curing from S. aureus. S. aureus strains to be cured were transformed with 1mg of
pEMPTY::sgRNA2 plasmid. Recombinant bacteria were selected on solid medium supplemented with
20mg ml21 Cm after 48 to 72 h of incubation at 28°C, and pEMPTY::sgRNA2 presence was confirmed by
PCR using primers 217 and 235. Positive clones were propagated in 5ml of TSB containing 20mg
ml21 Cm for 8 h (200 rpm, 28°C). Portions (100ml) of these cultures were used to inoculate 15ml of fresh
TSB medium supplemented with 20mg ml21 Cm and 100 ng ml21 anhydrotetracycline. After incubation
for 16 h at 200 rpm and 28°C, serial dilutions of the cultures were plated on antibiotic-free TSA medium
and on TSA containing a selective agent (Cd, Ery, or Lin) to which plasmid-located genes are known to
confer resistance. The presence/absence of natural plasmids was doubled checked in colonies isolated
on the general medium by streaking on general and selective medium and PCR amplification. The pres-
ence of plasmids pMW2, pLAC-p03, pN315, pUR2940, pUR1902, and pUR3912 was checked using pri-
mers 365 and 366; the presence of pUR1841 was checked using primers 253 and 255; the presence of
pUR2355 was checked using primers 437 and 438.
To remove pEMPTY::sgRNA2, and since it carries the temperature-sensitive origin of replication
pE194ts-ori, a natural plasmid-free colony was grown in 15ml of nonselective TSB medium for 16 h at
37°C with shaking. Serial dilutions of the culture were made and plated on antibiotic-free TSA medium
and medium containing 20mg ml21 Cm. Colonies obtained on antibiotic-free TSA were doubled checked
for the absence of pEMPTY::sgRNA2 by streaking on general and selective medium and PCR amplifica-
tion (primers 217 and 235).
Fitness evaluation. Overnight cultures of plasmid-free and plasmid-carrying strains were diluted to
an optical density at 595 nm (OD595) of 0.1 in fresh TSB medium. Portions (5ml) of the adjusted cultures
were used to inoculate 195ml of fresh TSB medium (10 replicates of each) using 96-well plates (Thermo
Fitness Cost of Plasmids in Staphylococcus aureus ®















































Scientific). Growth kinetics were assayed using a Synergy H1 hybrid multimode microplate reader
(Biotek). Nonselective TSB medium was used in all cases. Growth data (OD595) were collected every 15
min for 24 h at 37°C with shaking (fast orbital shaking; 425 cpm). All the experiments were repeated at
least three times, and results from one representative experiment are shown.
Two parameters were extracted from growth dynamics: the area under the growth curve (culture
total growth) and the duration of the lag phase (45). The mathematical procedure to calculate the area
under the growth curve consisted of integrating the OD595 values generated from time zero to 6.5 h for
each culture. To determine the length of the lag phase, the maximum slope of the growth curve based
on 5 consecutive time points was considered the start of the exponential phase of growth.
Evolution assays. Three plasmid-carrying clones selected from three independent transformation
rounds of the parental plasmid-free strain MW2 PFt0 with plasmids pMW2t0, pUR2940t0, pN315t0, and
pLAC-p03t0 were propagated in 3ml of antibiotic-free TSB medium, and every 12 h, 3ml of each culture
was transferred to 3ml of fresh TSB medium for a total duration of 35 days. At the end of the evolution
process, cultures were plated on TSA medium containing 0.05mM cadmium, and a resistant colony was
selected for each culture.
Evolution of strain MW2 PFt0 transformed with evolved pUR2940t35 plasmids and strain C2940 was
performed as described above but for a period of 14 days.
Monitoring of plasmid-carrying cells during the evolution assays. Every 7 days, evolving cultures
were serially diluted and plated on TSA and on TSA containing 0.05mM Cd or 10mg ml21 Ery in the case
of the C2940 strain. According to the number of resistant colonies, the percentage of plasmid-carrying
colonies was calculated. Also, PCR amplification (primers 365 and 366) was randomly performed to dis-
card the emergence of spontaneous mutants on TSA supplemented with Cd and ensure plasmid
presence.
Quantification of plasmid copy number. Plasmid copy number was determined by quantitative
PCR (qPCR) using a QuantStudio 12K Flex real-time PCR system (Life Technologies) and Power SYBR
green PCR master mix (Applied Biosystems) at a final DNA concentration of 0.2 ng ml21. For that, DNA
extraction was performed with the GenElute bacterial genomic DNA kit (Sigma), DNA was quantified,
and 1mg of genomic DNA was digested with 1ml of FastDigest EcoRI for 2 h at 37°C. EcoRI was inacti-
vated at 80°C for 15min. qPCR was performed for each extraction in triplicate. The amplification condi-
tions were initial denaturation for 10min at 95°C, followed by 40 cycles of denaturation for 15 s at 95°C,
annealing (Table S3, qPCR), and extension for 1min at 57°C. After the amplification was complete, a
melting curve analysis was performed by cooling the reaction mixture to 60°C and then heating slowly
to 95°C. Primers used for analysis are described in Table S3 (qPCR). The number of plasmid copies per
chromosome was calculated (7) as [(1 1 Ec)
CTc/(1 1 Ep)
CTp]  (Sc/Sp), where Ec and Ep are the efficiencies
of the chromosomal and plasmid qPCRs (relative to 1), CTc and CTp are the threshold cycles of the chro-
mosomal and plasmid reactions, and Sc and Sp are the sizes of the chromosomal and plasmid amplicons
(in base pairs).
To calculate primer efficiency, serial dilutions of the MW2 wild type EcoRI-digested genomic DNA
were used to create a standard curve for each pair of primers. The first point of the curve was dilution
1022. Three technical replicates were made for each point. The average cycle threshold (CT) was
obtained for each point and plotted against the log10 of each sample dilution. The slope of the regres-
sion was obtained, and the efficiency of the primers was calculated using the following formula (8):
(101/slope 2 1)  100.
Next-generation sequencing and data processing. Deep sequencing of DNA samples was per-
formed by MicrobesNG (Birmingham, United Kingdom) using Illumina technology. Genome assembly
and plasmid reconstruction were performed with PLACNETw (46, 47). Short-read sequence data were
mapped to reference strain S. aureus MW2 (NC_003923.1) or reference plasmid pUR2940 (HF583292.1)
by using Snippy (v4.3.6) (https://github.com/tseemann/snippy). Genomes and variant calling files were
visualized using IGV (48). BLAST Ring Image Generator (BRIG) was used for comparing plasmid variants
(49).
Statistics. Statistical analyses were performed with the GraphPad Prism 5.01 program. A one-way
analysis of variance combined with the Bonferroni multiple post hoc test was used to analyze statistical
significance in the study of the initial fitness cost after MW2 PFt0 transformation with different plasmids.
A nonparametric Mann-Whitney U test was used to assess differences in the analysis of plasmid copy
number and fitness cost. Differences with a P value of ,0.05 were considered significant. Box plots
show medians (horizontal black lines), lower and upper quartiles, and extreme values (whiskers).
Data availability. The nucleotide sequence of plasmid pEMPTY::sgRNA2 has been deposited in the
GenBank database under accession number MW367468. The nucleotide sequences of plasmid pUR2940
and its evolved fit variant determined in this study have been deposited in the GenBank database under
accession numbers MW367469 and MW367470, respectively.
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